We encountered a case of AML with an NPM1 mutation, along with IDH2 and SETD2 mutations, which morphologically and immunologically resembled APL but lacked the PML::RARA fusion gene, resulting in a diagnosis of APL-like AML with an NPM1 mutation. This evidence concerns the gene RARA and acute myeloid leukemia.